Premium
Strategies for managing Asherman's syndrome and endometrial atrophy: Since the classical experimental models to the new bioengineering approach
Author(s) -
MiguelGómez Lucía,
Romeu Mónica,
Pellicer Antonio,
Cervelló Irene
Publication year - 2021
Publication title -
molecular reproduction and development
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.745
H-Index - 105
eISSN - 1098-2795
pISSN - 1040-452X
DOI - 10.1002/mrd.23523
Subject(s) - endometrium , biology , population , infertility , pregnancy , bioinformatics , gynecology , medicine , endocrinology , genetics , environmental health
Endometrial function is essential for embryo implantation and pregnancy, but managing endometrial thickness that is too thin to support pregnancy or an endometrium of compromised functionality due to intrauterine adhesions is an ongoing challenge in reproductive medicine. Here, we review current and emerging therapeutic and experimental options for endometrial regeneration with a focus on animal models used to study solutions for Asherman's syndrome and endometrial atrophy, which both involve a damaged endometrium. A review of existing literature was performed that confirmed the lack of consensus on endometrial therapeutic options, though promising new alternatives have emerged in recent years (platelet‐rich plasma, exosomes derived from stem cells, bioengineering‐based techniques, endometrial organoids, among others). In the future, basic research using established experimental models of endometrial pathologies (combined with new high‐tech solutions) and human clinical trials with large population sizes are needed to evaluate these emerging and new endometrial therapies.